Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 24018803)

1.

Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.

Noh SJ, Kang MJ, Kim KM, Bae JS, Park HS, Moon WS, Chung MJ, Lee H, Lee DG, Jang KY.

Pathology. 2013 Oct;45(6):574-80. doi: 10.1097/PAT.0b013e3283652c7a.

PMID:
24018803
2.

Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.

Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH, Park HS, Lee H, Chung MJ, Kang MJ, Lee DG, Moon WS, Jang KY.

Clin Cancer Res. 2009 Jul 1;15(13):4453-9. doi: 10.1158/1078-0432.CCR-08-3329. Epub 2009 Jun 9.

3.

Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

Lee H, Kim KR, Noh SJ, Park HS, Kwon KS, Park BH, Jung SH, Youn HJ, Lee BK, Chung MJ, Koh DH, Moon WS, Jang KY.

Hum Pathol. 2011 Feb;42(2):204-13. doi: 10.1016/j.humpath.2010.05.023. Epub 2010 Nov 5.

PMID:
21056897
4.

Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.

Kim JR, Moon YJ, Kwon KS, Bae JS, Wagle S, Yu TK, Kim KM, Park HS, Lee JH, Moon WS, Lee H, Chung MJ, Jang KY.

PLoS One. 2013 Sep 3;8(9):e74738. doi: 10.1371/journal.pone.0074738. eCollection 2013.

5.

Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.

Park HS, Bae JS, Noh SJ, Kim KM, Lee H, Moon WS, Chung MJ, Kang MJ, Lee DG, Jang KY.

Transl Oncol. 2013 Jun 1;6(3):370-81. Print 2013 Jun.

6.

Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.

Wu M, Wei W, Xiao X, Guo J, Xie X, Li L, Kong Y, Lv N, Jia W, Zhang Y, Xie X.

Med Oncol. 2012 Dec;29(5):3240-9. doi: 10.1007/s12032-012-0260-6. Epub 2012 Jun 4.

PMID:
22661383
7.

CD151 expression can predict cancer progression in clear cell renal cell carcinoma.

Yoo SH, Lee K, Chae JY, Moon KC.

Histopathology. 2011 Jan;58(2):191-7. doi: 10.1111/j.1365-2559.2011.03752.x.

PMID:
21323946
8.

Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.

Tseng RC, Lee CC, Hsu HS, Tzao C, Wang YC.

Neoplasia. 2009 Aug;11(8):763-70.

9.

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

Clin Cancer Res. 2007 Dec 15;13(24):7388-93.

10.

SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer.

Jung W, Hong KD, Jung WY, Lee E, Shin BK, Kim HK, Kim A, Kim BH.

Korean J Pathol. 2013 Aug;47(4):332-9. doi: 10.4132/KoreanJPathol.2013.47.4.332. Epub 2013 Aug 26.

11.

Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.

Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS.

BJU Int. 2012 Dec;110(11 Pt B):E673-8. doi: 10.1111/j.1464-410X.2012.11498.x. Epub 2012 Sep 14.

PMID:
22973869
12.

SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.

Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, Lee NR, Kwak JY, Park BH, Park HS, Chung MJ, Kang MJ, Lee DG, Kim HS, Shim H, Moon WS.

Am J Surg Pathol. 2008 Oct;32(10):1523-31. doi: 10.1097/PAS.0b013e31816b6478.

PMID:
18724249
13.

Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.

Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.

Urology. 2007 May;69(5):843-8.

PMID:
17482919
14.

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.

Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.

J Urol. 2009 Nov;182(5):2144-9. doi: 10.1016/j.juro.2009.07.015. Epub 2009 Sep 15.

PMID:
19758660
15.

Balance between SIRT1 and DBC1 expression is lost in breast cancer.

Sung JY, Kim R, Kim JE, Lee J.

Cancer Sci. 2010 Jul;101(7):1738-44. doi: 10.1111/j.1349-7006.2010.01573.x. Epub 2010 Mar 24.

PMID:
20412117
16.

Negative regulation of the deacetylase SIRT1 by DBC1.

Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, Gu W.

Nature. 2008 Jan 31;451(7178):587-90. doi: 10.1038/nature06515.

17.

Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma.

Li W, Liu M, Feng Y, Xu YF, Che JP, Wang GC, Zheng JH, Gao HJ.

Int J Clin Exp Pathol. 2013 May 15;6(6):1086-94. Print 2013.

18.

Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Wu XR, Chen YH, Liu DM, Sha JJ, Xuan HQ, Bo JJ, Huang YR.

Med Oncol. 2013 Mar;30(1):346. doi: 10.1007/s12032-012-0346-1. Epub 2012 Dec 22.

PMID:
23263830
19.

Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.

Cho DS, Joo HJ, Oh DK, Kang JH, Kim YS, Lee KB, Kim SJ.

Yonsei Med J. 2005 Feb 28;46(1):133-40.

20.

Expression of endothelin 2 and localized clear cell renal cell carcinoma.

Bot BM, Eckel-Passow JE, LeGrand SN, Hilton T, Cheville JC, Igel T, Parker AS.

Hum Pathol. 2012 Jun;43(6):843-9. doi: 10.1016/j.humpath.2011.07.011. Epub 2011 Nov 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk